BioAtla Signs Deal to Sell Up to $40 Million in Shares to Yorkville

• BioAtla entered a standby equity purchase agreement with Yorkville on October 15, 2026, to sell up to $40 million in common stock.
• The 36-month facility replaces a $15 million agreement; share sales remain at the company's option.
• Yorkville's purchase price will equal 97% of the lowest daily VWAP during the three-trading-day pricing period, subject to minimum-price conditions.
• The company owes a $500,000 commitment fee, payable in two equal installments in cash or Commitment Fee Warrants.
• On October 16, 2026, it issued Commitment Fee Warrants exercisable for 182,110 shares to cover the first installment; the remainder is due December 31.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioAtla Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-425553), on October 20, 2026, and is solely responsible for the information contained therein.